Skip to main navigation Skip to search Skip to main content

Fixed-dose capecitabine is feasible: Results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer

  • Michelle A. Rudek
  • , Roisin M. Connolly
  • , Janelle M. Hoskins
  • , Elizabeth Garrett-Mayer
  • , Stacie C. Jeter
  • , Deborah K. Armstrong
  • , John H. Fetting
  • , Vered Stearns
  • , Laurie A. Wright
  • , Ming Zhao
  • , Stanley P. Watkins
  • , Howard L. McLeod
  • , Nancy E. Davidson
  • , Antonio C. Wolff

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Fixed-dose capecitabine is feasible: Results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science